ELMMB logo
Facebook logo Twitter logo
Menu
Drug Alerts and Withdrawals

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 16th Nov 2020              MHRA Press Release - Sleep disorder drug modafinil linked to increase risk of birth defects and also to 
                                                                                reduce effectiveness of contraception
 30th July 2020               MHRA Press Release - Skin creams dried on fabric can lead to fire deaths - new awareness campaign
 3rd July 2020                 MHRA Press ReleaseDon’t rely on temperature screening products for detection of coronavirus (COVID-19),  
                                         says MHRA
 26th May 2020              MHRA Press Release - MHRA supports use of remdesivir as the first medicines to treat COVID-19 in the UK
 6th May 2020                MHRA Press Release - NEW Yellow Card COVID-19 reporting site
                                                     

MHRA Company-led Drug alerts

click here to access the most recent alerts

Items In This Category

 TitleCreatedDownload
application/pdfSyonell 250_500mg tablets Class 4 meds recall EL__21_A_11 040521.pdf (78KB)04/05/2021Download
 Lupin Healthcare (UK) Limited has informed us of a discrepancy with the product packaging for several batches of Syonell 250mg Gastro-Resistant Tablets and Syonell 500mg Gastro-Resistant Tablets.... 
application/pdfTrimethorpim 200mg tab Class 2 meds recall EL__21_A_10_FINAL 220421.pdf (121KB)22/04/2021Download
 Ennogen Pharma Limited are recalling the above batch as a precautionary measure due to the investigation of market complaints. The Marketing Authorisation Holder has received two complaints related... 
application/pdfItraconazole 10mg per ml oral soln class 3 meds recallEL__21_A_08.pdf (91KB)15/03/2021Download
 Thame Laboratories are recalling the above batches due to an issue with the container closure (childresistant cap). The Marketing Authorisation Holder has received a number of complaints regarding... 
application/pdfEasyhaler Salbutabol Sulfate 100mcg & 200mcg per actuation inhaletion powder EL__21_A_06_Final.pdf (132KB)01/03/2021Download
 Orion Corporation T/A Orion Pharma (UK) Ltd are recalling the above batches as a precautionary measure due to an issue related to moulding defects in the bulk chambers where the inhalation powder is... 
application/pdfPalexia 20mg per ml oral soln Class 2 meds recall EL__21_A_02_Final 080221.pdf (178KB)08/02/2021Download
 Grünenthal Ltd has informed us of a potential microbial contamination during routine stability testing for the batches listed in this recall. Due to the detection of possible Burkholderia... 
application/pdfKolanticon Gel 500ml Class 3 meds recall_030221EL__21_A_01_Final.pdf (117KB)03/02/2021Download
 Brief description of the problem Intrapharm Laboratories Ltd has received a number of complaints that the product consistency is lumpy. The investigation has confirmed through review of the retained... 
application/pdfZerbaxa 1g_0.5g Powder for Conc for sol Class 2 Meds recall EL__20_A_60 171220.pdf (122KB)17/12/2020Download
 Merck Sharp & Dohme Limited is recalling the above batches due to the presence of Ralstonia pickettii in recent batches that were manufactured. The above batches are recalled as a precautionary... 
application/pdfCo-careldops 25_100mg Class 4 Medicines Recall EL__20_A_59_Final 151220.pdf (140KB)15/12/2020Download
 Fairmed Healthcare GmbH has informed us of a discrepancy on the product packaging for the above batches. The discrepancy relates to the incorrect spelling of one of the active pharmaceutical... 
application/pdfSimvador tablets Class 3 medicines recall 031220 EL__20_A_57i.pdf (118KB)03/12/2020Download
 Lupin Healthcare (UK) Limited has informed us that the affected batches above (also distributed by Discovery Pharmaceuticals/Dexcel Pharma Limited) have been packaged with a version of patient... 
application/pdfLargactil 50mg in 2mL sol for inj Aventis Pharma Class 2 meds recallEL__20_A_56.pdf (93KB)03/12/2020Download
 Sanofi is recalling the above batches due to out of specification results obtained for the impurity chlorpromazine sulphoxide, which was suspected to be caused by increased oxidation as a result of... 
application/pdfBetahistine 8mg & 16mg tabs kent pharma Class 2 meds recall 261120EL__20_A_55.pdf (97KB)03/12/2020Download
 Kent Pharmaceuticals Ltd has informed us that the affected batches above are contaminated with theophylline due to a cross-contamination issue identified with an excipient that was used in the... 
application/pdfKolanticon Gel 200ml Class 4 meds recall EL__20_A_51_Final091120.pdf (130KB)09/11/2020Download
 Intrapharm Laboratories Ltd has informed us that there is a difference in dosage instructions between the carton and label. The Patient Information Leaflet (PIL) and bottle label contain the correct... 
Page: [1] [2] [3] [4] [5] [6] [7] [8]
[ Next » ]